METOLAZONE
- Product NDC
- 71406-114
- 11-digit product format
- 714060114
- Labeler code
- 71406
- Product ID
- 71406-114_ef18ba0e-e542-469b-e053-2995a90a46d8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- metolazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- AACE Pharmaceuticals, Inc.
- Application
- ANDA216216
- Marketing category
- ANDA
- Marketing start
- 2021-09-24
- Marketing end
- 0000-00-00
- Substance
- METOLAZONE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide-like Diuretic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71406-114-01 | 71406011401 | 100 TABLET in 1 BOTTLE (71406-114-01) | 100 tablet | 2021-09-24 | 0000-00-00 | No | No | Current |
| 71406-114-10 | 71406011410 | 1000 TABLET in 1 BOTTLE (71406-114-10) | 1000 tablet | 2021-09-24 | 0000-00-00 | No | No | Current |